| 2007
Ann
P. Streissguth, University of Washington School of Medicine
Fetal Alcohol Spectrum Disorders from Teratology to Public Health
2006
George
P. Daston, Procter & Gamble Company
Genomics and Assessment of Developmental Risks
2005
Anthony R. Scialli, M.D., Sciences International,
Inc.
Clinicians
2004
Carl L. Keen, University of California, Davis
The Critical Role of Mocronutrients in Pregnancy
Outcome: Zinc as an Illustration
2003
Patricia Rodier, University of Rochester
Autism as a Birth Defect
2002
Kenneth L. Jones
University of California, San Diego
From Recognition to Responsibility: David Smith, Josef Warkany
and the Fetal Alcohol Syndrome in the 21st Century.
2001
Philip E. Mirkes
Department of Pediatrics, University of Washington,
Seattle, Washington
To Die, Or Not To Die: That is the Question
2000
William J. Scott, Jr.
University of Cincinnati
Alteration of pattern formation as a mechanism of teratogenesis
1999
Carol Kimmel
U.S. Environmental Protection Agency
Improving the science for predicting risks to children's health
1998
John Gerhart
University of California, Berkeley
Signal transduction pathways in development
1997
Godfrey P. Oakley, Jr.
Centers for Disease Control and Prevention
Preventing birth defects—rubella, alcohol, and folic
acid are better models then thalidomide, valproic acid, and accutane
1996
William Webster
University of Sydney, Sydney, Australia
Rubella to retinoids, rodents, risks, and reactions
|
|
1995
Andrew G. Hendrickx
University of California, Davis
Primate teratology in perspective
1994
Lewis B. Holmes
Massachusetts General Hospital
Clinical studies of teratogenesis: Observations and challenges
1993
Heinz Nau
Institute for Toxicology, Berlin, Germany
From species differences to development of safer drugs:
The role of pharmacokinetics and metabolism studies
1992
Robert L. Brent
Jefferson Medical College
The impact of radiation research on the understanding of
teratology principles
1991
F. Clarke Fraser
McGill Centre for Human Genetics, Montreal, Canada
A personal perception of public perceptions of teratogenetic
risks
1990
Devendra M. Kochhar
Jefferson Medical College
Role of retinoic acid as a morphogen and a teratogen
1989
E. Marshall Johnson
Jefferson Medical College
The natural history for possible scoring of chemical exposures
potentially hazardous to human embryonic development
1988
Thomas H. Shepard
University of Washington
Borderlines between human embryology, teratology, and medicine
1987
Kurt Benirschke
University of California, San Diego
You need a sympathetic pathologist—the borderland
of embryology and pathology revisited
1986
Philip Leder
Harvard Medical School
Insertional mutagenesis
1985
Bengt K–llØn
University of Lund, Lund, Sweden
Searching for teratogenic risks with the aid of malformation
registries
|